XML 56 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
EARNINGS (LOSS) PER SHARE (''EPS'') (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Computation of Basic Earnings (Loss) Per Share:        
Net income (loss) $ 14,104 $ 40,859 $ (41,980) $ 70,512
Less: net income allocated to participating securities (939) (2,641)   (4,787)
Net income (loss) for basic EPS calculation 13,165 38,218 (41,980) 65,725
Total weighted average shares outstanding - basic 89,523,000 86,321,000 83,003,000 85,783,000
Less: weighted average participating shares outstanding (5,958,000) (5,578,000)   (5,824,000)
Weighted average common shares outstanding - basic 83,565,000 80,743,000 83,003,000 79,959,000
Basic earnings (loss) per common share (in dollars per share) $ 0.16 $ 0.47 $ (0.51) $ 0.82
Computation of Diluted Earnings (Loss) Per Share:        
Net income (loss) 14,104 40,859 (41,980) 70,512
Less: net income allocated to participating securities (939) (2,641)   (4,787)
Add: interest expense, net of tax, on Convertible Notes   3,552   10,446
Net income (loss) for diluted EPS calculation $ 13,165 $ 41,770 $ (41,980) $ 76,171
Weighted average common shares outstanding - basic 83,565,000 80,743,000 83,003,000 79,959,000
Add: dilutive effect of common stock equivalents (in shares)   12,939,000   12,938,000
Weighted average common shares outstanding - diluted 83,565,000 93,682,000 83,003,000 92,897,000
Diluted earnings (loss) per common share (in dollars per share) $ 0.16 $ 0.45 $ (0.51) $ 0.82
Antidilutive shares        
Strike price of warrants (in dollars per share) $ 14.945      
Common stock issued in connection with restricted stock awards (in shares) 2,773,000   2,917,000  
Unvested restricted stock awards, canceled (in shares) 8,000   116,000  
Unvested restricted stock
       
Antidilutive shares        
Antidilutive shares excluded from calculation of EPS     6,225,000  
Stock option awards
       
Antidilutive shares        
Antidilutive shares excluded from calculation of EPS 2,293,000 2,386,000 2,293,000 2,386,000